IRE favicon


Resource ID: #12239
Subject: Health Care
Source: Wall Street Journal (New York)
Date: Oct. 23


The Wall Street Journal reports that Johnson & Johnson's new "stent," a simple device that props clogged arteries open, is a hit but the cost is worrying hospitals. This device requires twice the hospital stay and costs significantly more than a similar, widely used procedure. The rush to use stents provokes controversy because approximately one million patients could be "stented" before any significant data on five-year results are available.

This file is not available for digital download. IRE members may place an order by emailing

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram